Valganciclovir 450mg Tablet

Valganciclovir 450mg Tablet is an antiviral medication used for the treatment and prevention of cytomegalovirus (CMV) infections, especially in immunocompromised patients such as organ transplant recipients and individuals with weakened immune systems. It works by inhibiting viral DNA replication, helping to control the spread of the virus in the body.

This medicine is commonly prescribed for CMV retinitis in patients with HIV/AIDS and for CMV prophylaxis following solid organ transplantation. Valganciclovir 450mg Tablet helps reduce viral load and lowers the risk of CMV-related complications when taken exactly as directed by a healthcare professional.

The Valganciclovir 450mg Tablet follows strict pharmaceutical quality standards to ensure consistent safety and effectiveness. This pharmaceutical product is widely used in hospitals, clinics, and healthcare institutions and plays an important role in long-term CMV infection management and prevention programs.

Product Features

• Contains 450 mg of valganciclovir as the active ingredient
• Antiviral medicine for CMV treatment and prevention
• Used in transplant and immunocompromised patients
• Helps suppress viral replication effectively
• Meets established pharmaceutical quality standards

How It Helps

• Inhibits viral DNA synthesis to prevent virus multiplication
• Helps treat cytomegalovirus (CMV) infections
• Reduces the risk of CMV disease after organ transplantation
• Supports long-term antiviral therapy outcomes
• Helps prevent progression of CMV-related complications